CVS Caremark reported better-than-expected fourth-quarter and full-year 2013 earnings before markets opened on Tuesday. First-quarter EPS guidance was better than expected. Shares were up 2.5% in premarket trading.
Paul Ausick In a new research report, J.P. Morgan analysts completed some exhaustive work and have narrowed down the list of stocks that should get the largest boost from the Affordable Care Act, or…
Drug store operator and health benefits management company CVS Caremark said Wednesday morning that it would stop selling cigarettes and other tobacco products at its 7,600 U.S. stores by October 1 of…
The National Retail Federation (NRF) has now released the holiday numbers, and the naysayers were proven wrong despite some of the worst December weather in years.
ThinkstockThe administration has basically admitted that the rollout and launch of the Affordable Care Act, or Obamacare, has been nothing short of a disaster so far. The website was never prepared to…
courtesy of RiteAidRite Aid Corp. (NYSE: RAD) has had one amazing recovery in its turnaround. There is an old-school $5.00 share price mark that many mutual funds and institutional investors (as well…
Jon C. Ogg ThinkstockThe second-quarter earnings parade has all but come to a end. One conclusion that is painfully obvious to the equity strategy team at Credit Suisse is that many companies beat earnings only…
ThinkstockWhen short interest, or the amount of any specific stock sold short, starts to decline, that is usually a flashing sign for investors to take a look behind the curtain. In general,…
August 7, 2013: U.S. equity markets opened lower this morning after more comments by Fed officials point toward a winding down of the central bank’s stimulus sooner rather than later. In Europe,…
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Wednesday, August 7, 2013. They include CVS Caremark, DaVita Healthcare, Zillow and Marathon Oil.
ThinkstockThe analysts at Lazard Capital continue to believe that underlying fundamentals for the top companies in the drug channel (distributors, retailers, etc.) remain sound. Prescription use has picked up over the past…
Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and…
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big drug companies like Pfizer,…
Jon OggInvestors and traders are always on the lookout for fresh research ideas from Wall St. that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research…
Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Apple Inc. (NASDAQ: AAPL) maintained Hold but price target cut to $420 from…
